ABT
Abbott Laboratories · Healthcare · Medical - Devices
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham +0.7% · posisi baru bersih -4.2% · formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 8.65M | $848.35M | n/a | n/a |
| Q2 2026 | 180 | 0 | 1.09B | $98.86B | +5 | −6 |
| Q1 2026 | 184 | +3 | 1.11B | $114.25B | +7 | −5 |
| Q4 2025 | 180 | +2 | 1.17B | $146.24B | +3 | n/a |
| Q3 2025 | 24 | 0 | 623.34M | $83.47B | +1 | −2 |
| Q2 2025 | 22 | 0 | 527.92M | $71.78B | +1 | −1 |
| Q1 2025 | 19 | 0 | 196.20M | $26.01B | +1 | −1 |
| Q4 2024 | 19 | -1 | 182.48M | $20.63B | n/a | −1 |
| Q3 2024 | 19 | 0 | 108.33M | $12.33B | +1 | −1 |
| Q2 2024 | 19 | n/a | 110.87M | $11.51B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasif) | 173.15M | +0.2% | $23.19B | 0.3% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (pasif) | 141.56M | +0.2% | $18.96B | 0.3% | ▲ Add | 2 | SEC ↗ ×22 |
| 3 | State Street Global Advisors ✦ (pasif) | 78.23M | -0.2% | $10.48B | 0.4% | ▼ Trim | 4 | SEC ↗ |
| 4 | JPMorgan Chase ✦ | 58.77M | n/a | $7.87B | 0.3% | n/c | 1 | SEC ↗ ×42 |
| 5 | Morgan Stanley ✦ | 38.63M | n/a | $5.17B | 0.3% | n/c | 1 | SEC ↗ ×22 |
| 6 | Geode Capital Management ✦ (pasif) | 38.54M | +0.7% | $5.14B | 0.3% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Wellington Management ✦ | 23.25M | -7.2% | $3.11B | 0.5% | ▼ Trim | 6 | SEC ↗ ×8 |
| 8 | Goldman Sachs Group ✦ | 16.13M | n/a | $2.16B | 0.3% | n/c | 1 | SEC ↗ ×6 |
| 9 | T. Rowe Price ✦ | 15.80M | +52.7% | $2.12B | 0.2% | ▲ Add | 6 | SEC ↗ ×2 |
| 10 | Fisher Asset Management ✦ | 12.03M | +1.4% | $1.61B | 0.6% | ▲ Add | 6 | SEC ↗ |
| 11 | Fidelity (FMR) ✦ | 11.59M | -14.5% | $1.55B | 0.1% | ▼ Trim | 2 | SEC ↗ ×7 |
| 12 | Capital World Investors ✦ | 8.93M | +0.5% | $1.20B | 0.2% | ▲ Add | 5 | SEC ↗ |
| 13 | Adage Capital Partners ✦ | 2.30M | +43.8% | $307.66M | 0.5% | ▲ Add | 6 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 1.16M | -37.8% | $154.36M | 0.1% | ▼ Trim | 6 | SEC ↗ ×6 |
| 15 | Arrowstreet Capital ✦ | 1.14M | +123.5% | $152.53M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 16 | PRIMECAP Management ✦ | 810.39K | -7.4% | $108.54M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 585.80K | Baru | $78.46M | 0.1% | New | 1 | SEC ↗ |
| 18 | Millennium Management ✦ | 474.83K | +180.9% | $63.60M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 119.23K | +109.6% | $15.97M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 64.59K | -17.6% | $8.65M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 39.84K | +534.5% | $5.34M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 22 | GAMCO Investors ✦ | 22.36K | -4.3% | $2.99M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 23 | Dodge & Cox ✦ | 17.32K | 0.0% | $2.32M | 0.0% | Held | 6 | SEC ↗ |
| 24 | Harris Associates (Oakmark) ✦ | 2.05K | -1.2% | $274,041 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Citadel Advisors | $78.46M | 0.1% |
Telah keluar
| Norges Bank | $3.03B | adalah 0.4% |
| Two Sigma Investments | $3.50M | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 3,058 pemegang, 1.35B saham, $133.47B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 27 lbr · $2,958
Officer, Director · 180.30K lbr · $20.95M
Officer, Director · 218.53K lbr · $25.26M
Officer · 5.85K lbr · $642,506
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi